Skip to main content
. 2020 Dec 26;22(1):183. doi: 10.3390/ijms22010183

Figure 9.

Figure 9

Relative survival of MCF-7, MDA-MB-231, and MCF-10A cells treated with (A) SUM (10–350 µg/mL) or (B) DMSO vehicle and analyzed by resazurin metabolic assay. Data were obtained from three independent experiments and significant differences were marked as * p < 0.05, ** p < 0.01, *** p < 0.001, vs. control cells (untreated).